Efficacy, Immunogenicity, and Safety of Two Doses of a Tetravalent Rotavirus Vaccine RRV-TV in Ghana With the First Dose Administered During the Neonatal Period

Background. Oral rhesus/rhesus-human reassortant rotavirus tetravalent vaccine (RRV-TV) was licensed in 1998 but withdrawn in 1999 due to a rare association with intussusception, which occurred disproportionately in infants receiving their first dose at ≥90 days of age. This study examined RRV-TV fo...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Armah, George E., Kapikian, Albert Z., Vesikari, Timo, Cunliffe, Nigel, Jacobson, Robert M., Burlington, D. Bruce, Ruiz, Leonard P.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2013
Soggetti:
Major Articles and Brief Reports
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3699001/
https://ncbi.nlm.nih.gov/pubmed/23599316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jit174
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi